What is the standard dosage of pazopanib/pazopanib?

Pazopanib is a targeted anti-cancer drug that is a multi-target tyrosine kinase inhibitor that can inhibit multiple receptor tyrosine kinases related to tumor growth and angiogenesis, including VEGFR, PDGFR and c-Kit. It is mainly used to treat advanced renal cell carcinoma and specific types of soft tissue sarcomas. According to the recommendations of global authoritative guidelines and drug inserts, its standard oral dosage is 800 mg once daily. It is recommended to take it on an empty stomach, that is, at least one hour before or two hours after meals to avoid food affecting drug absorption. This dose is considered to have good efficacy and acceptable safety in most patients.

However, due to obvious metabolic differences among individuals, many patients will experience some dose-related side effects during the use of pazopanib, such as hypertension, elevated liver enzymes, diarrhea, skin discoloration, decreased appetite, etc. For patients who experience moderate to severe adverse reactions, doctors may adjust the dose to 600mg or even 400mg depending on the specific situation to achieve the best balance between tolerability and efficacy. In addition, patients with hepatic insufficiency have a reduced ability to metabolize this drug and need to adjust the dose carefully. For patients with moderate hepatic impairment (Child-Pugh category B), it is recommended to lower the initial dose to 200 mg and closely monitor liver function indicators during treatment.

It is worth noting that pazopanib has the risk of potential drug interactions. For example, coadministration withCYP3A4 enzyme inhibitors or inducers may change its blood concentration. Therefore, patients should consult their doctor in advance when taking other drugs (such as anti-epileptic drugs, proton pump inhibitors, certain antibiotics, etc.). In addition, it is not recommended to take this drug with grapefruit juice, as these foods may significantly increase its plasma concentration and increase the risk of toxicity.

In short, during long-term treatment, multiple tests such as liver function, kidney function, electrocardiogram and blood pressure should be carried out regularly to ensure the safety of medication.

Reference materials:https://www.votrient.com/